Chronic kidney disease (CKD) is a major health problem worldwide. Although relatively
uncommon in children, it can be a devastating illness with many long-term consequences …

Achieving normal growth is one of the most challenging problems in the management of
children with chronic kidney disease (CKD). Treatment with recombinant human growth …

Background The 2011 annual report of the North American Pediatric Renal Transplant
Cooperative Study (NAPRTCS) registry comprises data on 6482 dialysis patients over the …

Chronic dialysis is rarely required during childhood. Despite technical advances that have
facilitated the treatment of even the youngest children, morbidity and mortality remain higher …

Mineral and bone disorder (MBD) is widely prevalent in children with chronic kidney disease
(CKD) and is associated with significant morbidity. CKD may cause disturbances in bone …

Children with chronic kidney disease (CKD) feature significant challenges to the
maintenance of adequate nutrition and linear growth. Moreover, the impaired nutritional …

Background and Objectives: The data on the prevalence of chronic kidney disease (CKD) in
the pediatric population are limited. The prevalence of CKD ranges from 56 to 74.7 cases …

The causes of growth failure in the setting of CKD are multifactorial. Attention to all the
details by optimizing nutritional, bone and mineral metabolism, correcting metabolic acidosis …

Growth failure is a hallmark in children with chronic kidney disease (CKD). Therefore, early
diagnosis and adequate management of growth failure is of utmost importance in these …

This review focuses on the evidence for the efficacy and safety of recombinant human
growth hormone (rhGH) therapy in children with all stages of chronic kidney disease (CKD) …